Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4864800
Max Phase: Preclinical
Molecular Formula: C13H14FN3O
Molecular Weight: 247.27
Molecule Type: Unknown
Associated Items:
ID: ALA4864800
Max Phase: Preclinical
Molecular Formula: C13H14FN3O
Molecular Weight: 247.27
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=c1cc(N2CCNCC2)c2cc(F)ccc2[nH]1
Standard InChI: InChI=1S/C13H14FN3O/c14-9-1-2-11-10(7-9)12(8-13(18)16-11)17-5-3-15-4-6-17/h1-2,7-8,15H,3-6H2,(H,16,18)
Standard InChI Key: ODPIHPCCOSWGME-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 247.27 | Molecular Weight (Monoisotopic): 247.1121 | AlogP: 1.08 | #Rotatable Bonds: 1 |
Polar Surface Area: 48.13 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.64 | CX Basic pKa: 8.93 | CX LogP: 0.63 | CX LogD: -0.91 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.79 | Np Likeness Score: -1.09 |
1. Hassan A, Badr M, Hassan HA, Abdelhamid D, Abuo-Rahma GEA.. (2021) Novel 4-(piperazin-1-yl)quinolin-2(1H)-one bearing thiazoles with antiproliferative activity through VEGFR-2-TK inhibition., 40 [PMID:33962153] [10.1016/j.bmc.2021.116168] |
Source(1):